Physician profile
Amanda Clark
NPI 1447512082
$504.10
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $413 · 2022: $51.35 · 2023: $39.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $39.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $39.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $234.08 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.36 | 2021 | |
| Nestle Healthcare Nutrition INC. | $34.77 | 2021 | |
| Janssen Biotech, INC. | $34.62 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.54 | 2021 | |
| Almirall LLC | $26.87 | 2023 | Seysara |
| Ironwood Pharmaceuticals, INC | $25.91 | 2021 | |
| Amgen INC. | $22.88 | 2021 | |
| Boston Scientific Corporation | $20.91 | 2021 | |
| Celgene Corporation | $15.36 | 2021 | |
| Vivus LLC | $14.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.